Login / Signup
Response to: Ruxolitinib withdrawal due to the COVID-19.
Tiziano Barbui
Alessandra Carobbio
Published in:
Leukemia (2021)
Keyphrases
</>
coronavirus disease
sars cov
respiratory syndrome coronavirus